Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes
Marica Meroni, Paola Dongiovanni, Miriam Longo, et al.
EBioMedicine (2020) Vol. 52, pp. 102658-102658
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 306
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Hideki Fujii, Norifumi Kawada
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3863-3863
Open Access | Times Cited: 212
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease
Oveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, et al.
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1634-1646.e7
Open Access | Times Cited: 113
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
Nature Medicine (2023) Vol. 29, Iss. 10, pp. 2643-2655
Open Access | Times Cited: 50
Hepatic glucose metabolism in the steatotic liver
Egeria Scoditti, Silvia Sabatini, Fabrizia Carli, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 319-334
Closed Access | Times Cited: 29
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas, Annette Schürmann
Molecular Metabolism (2020) Vol. 50, pp. 101111-101111
Open Access | Times Cited: 117
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
K. Teo, Kushala Abeysekera, Leon A. Adams, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 20-30
Open Access | Times Cited: 107
Loss of hepatic Mboat7 leads to liver fibrosis
Veera Raghavan Thangapandi, Oskar Knittelfelder, Mario Brosch, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 940-950
Open Access | Times Cited: 100
Nutrition and Genetics in NAFLD: The Perfect Binomium
Marica Meroni, Miriam Longo, Alice Rustichelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2986-2986
Open Access | Times Cited: 91
Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity
William J. Valentine, K. Yanagida, Hiroki Kawana, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 1, pp. 101470-101470
Open Access | Times Cited: 82
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Metabolism (2021) Vol. 117, pp. 154708-154708
Closed Access | Times Cited: 80
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 759-788
Open Access | Times Cited: 78
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Paola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 7
Open Access | Times Cited: 56
iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies
Victoria Palasantzas, Isabel Tamargo-Rubio, Kieu T. T. Le, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 268-284
Open Access | Times Cited: 36
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
Marica Meroni, Miriam Longo, Anna Ludovica Fracanzani, et al.
EBioMedicine (2020) Vol. 57, pp. 102866-102866
Open Access | Times Cited: 58
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
Mingfeng Xia, Preethi Chandrasekaran, Shunxing Rong, et al.
Journal of Lipid Research (2020) Vol. 62, pp. 100031-100031
Open Access | Times Cited: 54
Genetics Is of the Essence to Face NAFLD
Marica Meroni, Miriam Longo, Giada Tria, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1359-1359
Open Access | Times Cited: 50
Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis
Sara Guerra, Gabriele Mocciaro, Amalia Gastaldelli
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Closed Access | Times Cited: 45
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100284-100284
Open Access | Times Cited: 43
NAFLD: genetics and its clinical implications
Dixa Sharma, Palash Mandal
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 9, pp. 102003-102003
Closed Access | Times Cited: 32
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Miriam Longo, Erika Paolini, Marica Meroni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 37
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Marica Meroni, Miriam Longo, Rosa Lombardi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 3, pp. 535-549
Open Access | Times Cited: 36
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Rosa Lombardi, Federica Iuculano, Giada Pallini, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8761-8761
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top